These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 380249)

  • 1. Naproxen and naproxen sodium in dysmenorrhea: development from in vitro inhibition of prostaglandin synthesis to suppression of uterine contractions in women and demonstration of clinical efficacy.
    Henzl MR; Izu A
    Acta Obstet Gynecol Scand Suppl; 1979; 87():105-17. PubMed ID: 380249
    [No Abstract]   [Full Text] [Related]  

  • 2. The effect of inhibitors of prostaglandin synthesis in primary dysmenorrhea studied with hysterometry.
    Joelsson I; Lalos O
    Acta Obstet Gynecol Scand Suppl; 1979; 87():45-49. PubMed ID: 380251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of primary dysmenorrhea with prostaglandin synthetase inhibitors--a promising therapeutic alternative.
    Lundström V
    Acta Obstet Gynecol Scand; 1978; 57(5):421-8. PubMed ID: 103358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endogenous prostaglandins in dysmenorrhea and the effect of prostaglandin synthetase inhibitors (PGSI) on uterine contractility.
    Lundström V; Gréen K; Svanborg K
    Acta Obstet Gynecol Scand Suppl; 1979; 87():51-6. PubMed ID: 111466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of naproxen-sodium on the intrauterine pressure and menstrual pain of dysmenorrheic patients.
    Csapo AI; Pulkkinen MO; Henzl MR
    Prostaglandins; 1977 Jan; 13(1):193-9. PubMed ID: 320630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of uterine activity by prostaglandin synthetase inhibitors.
    Pulkkinen MO
    Acta Obstet Gynecol Scand Suppl; 1979; 87():39-43. PubMed ID: 111465
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Naproxen and indomethacin in the treatment of primary dysmenorrhea.
    Kajanoja P; Vesanto T
    Acta Obstet Gynecol Scand Suppl; 1979; 87():87-9. PubMed ID: 380254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naproxen sodium in dysmenorrhea secondary to endometriosis.
    Kauppila A; Rönnberg L
    Obstet Gynecol; 1985 Mar; 65(3):379-83. PubMed ID: 3883265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin synthetase inhibitors and dysmenorrhea. A survey and personal clinical experience.
    Jacobson J; Cavalli-Björkman K; Lundström V; Nilsson B; Norbeck M
    Acta Obstet Gynecol Scand Suppl; 1979; 87():73-9. PubMed ID: 111467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naproxen sodium, aspirin, and placebo in primary dysmenorrhea. Reduction of pain and blood levels of prostaglandin F2-alpha metabolite.
    Rosenwaks Z; Jones GS; Henzl MR; Dubin NH; Ghodgaonkar RB; Hoffman S
    Am J Obstet Gynecol; 1981 Jul; 140(5):592-8. PubMed ID: 7246695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary dysmenorrhea: the therapeutic challenge.
    Henzl MR; Massey S; Hanson FW; Buttram VC; Rosenwaks Z; Pauls FD
    J Reprod Med; 1980 Oct; 25(4 Suppl):226-35. PubMed ID: 7001022
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical experience of naproxen in the treatment of primary dysmenorrhea.
    Dandenell LO; Lalos O; Lisciak J; Sandström B; Barany S; Nilsson B
    Acta Obstet Gynecol Scand Suppl; 1979; 87():95-100. PubMed ID: 380256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Naproxen sodium in dysmenorrhea. Its influence in allowing continuation of work/school activities.
    Hanson FW; Izu A; Henzl MR
    Obstet Gynecol; 1978 Nov; 52(5):583-7. PubMed ID: 364357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Naproxen in the treatment of OC-resistant primary dysmenorrhea. A double-blind cross-over study.
    Jacobson J; Lundström V; Nilsson B
    Acta Obstet Gynecol Scand Suppl; 1983; 113():87-9. PubMed ID: 6407271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current status of the etiology and management of dysmenorrhea in adolescence.
    Alvin PE; Litt IF
    Pediatrics; 1982 Oct; 70(4):516-25. PubMed ID: 6812011
    [No Abstract]   [Full Text] [Related]  

  • 16. A rationale for the treatment of dysmenorrhea.
    Csapo AI
    J Reprod Med; 1980 Oct; 25(4 Suppl):213-21. PubMed ID: 7001020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of naproxen-sodium on the prostaglandin concentrations of the menstrual blood and uterine "jet-washings" in dysmenorrheic women.
    Pulkkinen MO; Henzl MR; Csapo AI
    Prostaglandins; 1978 Mar; 15(3):543-50. PubMed ID: 351717
    [No Abstract]   [Full Text] [Related]  

  • 18. Diflunisal compared with naproxen in the treatment of dysmenorrhea.
    Kajanoja P; Kauste K
    Prostaglandins Leukot Med; 1984 Aug; 15(2):153-8. PubMed ID: 6387717
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials.
    Henzl MR; Buttram V; Segre EJ; Bessler S
    Am J Obstet Gynecol; 1977 Apr; 127(8):818-23. PubMed ID: 322491
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ibuprofen and naproxen-sodium in the treatment of primary dysmenorrhea: a double-blind cross-over study.
    Milsom I; Andersch B
    Int J Gynaecol Obstet; 1985 Sep; 23(4):305-10. PubMed ID: 2866117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.